I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 36% ± 8% | |
| glutamatergic neuron | 3 studies | 31% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 36% ± 8% | |
| glutamatergic neuron | 3 studies | 31% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1902.65 | 459 / 459 | 100% | 11.59 | 1117 / 1118 |
| thymus | 100% | 2887.58 | 653 / 653 | 100% | 12.01 | 604 / 605 |
| prostate | 100% | 2175.12 | 245 / 245 | 100% | 8.89 | 501 / 502 |
| brain | 100% | 1432.18 | 2635 / 2642 | 100% | 13.20 | 705 / 705 |
| lung | 100% | 2089.12 | 577 / 578 | 100% | 10.26 | 1153 / 1155 |
| adrenal gland | 100% | 4923.22 | 258 / 258 | 100% | 11.92 | 229 / 230 |
| ovary | 100% | 4235.96 | 180 / 180 | 100% | 11.11 | 428 / 430 |
| uterus | 100% | 2777.56 | 170 / 170 | 99% | 8.47 | 456 / 459 |
| pancreas | 100% | 1589.77 | 327 / 328 | 99% | 8.32 | 177 / 178 |
| esophagus | 100% | 1684.49 | 1444 / 1445 | 99% | 9.20 | 181 / 183 |
| bladder | 100% | 2526.62 | 21 / 21 | 98% | 6.58 | 496 / 504 |
| kidney | 100% | 1771.69 | 89 / 89 | 98% | 9.05 | 885 / 901 |
| intestine | 100% | 1823.17 | 966 / 966 | 97% | 5.79 | 513 / 527 |
| stomach | 100% | 1531.36 | 359 / 359 | 97% | 6.54 | 278 / 286 |
| skin | 97% | 937.51 | 1762 / 1809 | 97% | 7.52 | 456 / 472 |
| liver | 99% | 987.40 | 224 / 226 | 86% | 4.13 | 348 / 406 |
| adipose | 100% | 2038.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2334.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.21 | 29 / 29 |
| muscle | 100% | 2463.06 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3016.40 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 12.15 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.31 | 1 / 1 |
| heart | 99% | 1307.30 | 856 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 2186.13 | 901 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 5.03 | 73 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF641 |
| Protein name | Zinc finger protein 641 |
| Synonyms | |
| Description | FUNCTION: Transcriptional activator. Activates transcriptional activities of SRE and AP-1. . |
| Accessions | ENST00000548932.5 ENST00000550342.1 ENST00000544117.6 [Q96N77-1] ENST00000301042.7 [Q96N77-1] ENST00000549125.5 H0YHX6 Q96N77 ENST00000448928.7 [Q96N77-3] F8VXJ5 F8VSM8 ENST00000550181.5 F8VZV7 ENST00000546874.1 ENST00000547026.6 [Q96N77-4] F8VZ73 |
